Laser Offers Hope For Heart Patients With No Alternatives

April 29, 1997

DURHAM, N.C. -- Using high-powered lasers to pierce new blood-carrying channels into ailing heart muscle, Duke University Medical Center heart surgeons are testing a promising new therapy for patients with coronary artery disease who have exhausted all other conventional forms of treatment.

Duke is the only medical center in the Southeast using the laser system, which has demonstrated promising results for the eight patients treated at the medical center since October.

"The laser gives us another tool for helping patients for whom we could do nothing else," said Duke surgeon Dr. James Lowe, who heads up the Duke investigation. "These patients typically have had multiple hospital admissions, they can't work or exercise and physical exertion of any kind causes crushing heart pain (angina). They are a tragic and unhappy group of patients because they are so incapacitated and we can do very little for them."

Duke and 12 other U.S. medical centers are conducting clinical trials of The Heart Laser, which was developed by PLC Medical Systems Inc., Milford, Mass. The company recently was granted expedited review of its premarket approval application for the Heart Laser by the U.S. Food and Drug Administration (FDA). To date, more than 350 patients have undergone the procedure in the United States.

The procedure, known as transmyocardial revascularization (TMR), opens new passageways in heart muscle that is still alive, but because of inadequate supply of blood, is not functioning properly.

"The patients we have treated with TMR have seen an average 80 percent decrease in their angina score after three months," Lowe said. "When we compare the scans of their hearts before the procedure and after three months, we can clearly see that more of the heart muscle is oxygenated and functional."

During the procedure, surgeons gain access to the heart through a six- to eight-inch incision through the patient's side. Once the surface of the heart is exposed, they fire short pulses of laser energy into the left ventricle -- the heart's main pumping chamber -- while it is engorged with blood. A computer synchronizes the laser pulses with the pumping of the heart, and the blood in the chamber keeps the laser burst from traveling any further.

Depending on the extent of the heart disease, the surgeons create 20 to 40 channels in the moribund heart muscle, and the holes on the heart's surface seal themselves with clotted blood and heal over. Patients typically go home after four days in the hospital.

"The patients are now doing things they couldn't before -- shopping, gardening, driving and other everyday activities -- and without debilitating pain," Lowe said. "They have also lessened the amount of heart medications. If these benefits are sustained over time, this will be another important therapy for a very sick group of patients."

Specifically, the procedure is approved for patients who have not responded to the two standard therapies for blocked or diseased coronary arteries: coronary artery bypass surgery or balloon angioplasty. In a bypass procedure, veins from the leg are used to redirect oxygen-rich blood around blockages and directly to heart muscle. In angioplasty, a tiny balloon is threaded through the arteries feeding the heart and inflated, clearing plaque blocking the artery.

"At this point, we do not know exactly why this procedure works," he explained. "We do know that there is new capillary growth into the new channels. It could be that when oxygen-rich blood reaches heart muscle starved for oxygen, growth factors are released that encourage the ingrowth of capillaries.

"In the laboratory, we are examining why the capillaries grow into the channels," Lowe said. "It could be that the addition of certain growth factors could improve outcomes. Once we figure out how it works, we can then make it work better."

Since it takes time for these new capillaries to grow, patients usually do not begin to see major improvements until three months after the procedure, and the improvement usually continues for nine to 12 months, Lowe said.

He added that it is too premature to consider using TMR as a routine surgical option for patients with coronary artery disease.

"Right now, the outcomes of coronary bypass are so good, and patients feel better right away, that I can't see the laser procedure supplanting it," Lowe said. "But for those who have failed all other therapies, TMR is quite promising."

In terms of cost, a typical TMR procedure ranges somewhere between those of angioplasty and bypass surgery.

Duke University Medical Center

Related Angioplasty Articles from Brightsurf:

Ticagrelor was not superior to clopidogrel to reduce heart attack risk during angioplasty
A new study found the rate of heart attack and severe complications before, during or soon after elective surgery to open a blocked artery was similar between patients treated with clopidogrel and those who received the more potent antiplatelet medication ticagrelor.

Study finds significant variability in doctors' angioplasty death rates
Some doctors have higher or lower than expected death rates from coronary angioplasty procedures, also known as percutaneous coronary intervention (PCI); however, doctors should not be judged solely on the rate of patients who die from the procedure.

Beta-blockers following angioplasty show little benefit for some older patients
Following coronary angioplasty, beta-blockers did not significantly improve mortality rates or reduce the number of future cardiovascular incidents for older patients with stable angina but no history of heart attack or heart failure, according to a study published today in the JACC: Cardiovascular Interventions.

Sleep disorders may predict heart events after angioplasty
People who have had procedures to open blocked heart arteries after acute coronary syndrome (ACS) may have a higher risk of death, heart failure, heart attack and stroke if they have sleep disorders, such as sleep apnea, compared to those who don't.

Reasons for hospital-level variations in bleeding post-angioplasty are unclear
The use of bleeding avoidance strategies has only a modest effect on the variation in bleeding rates post-angioplasty among hospitals performing this procedure, leaving about 70 percent of the causes for this variation unexplained, according to a study published today in JACC: Cardiovascular Interventions.

US prediction models for kidney injury following angioplasty hold up in Japan
Models developed by the American College of Cardiology NCDR CathPCI Registry to predict the likelihood of angioplasty patients developing acute kidney injury and acute kidney injury requiring dialysis have proven to be effective among patients in Japan.

IV beta blockers before angioplasty are safe, but offer no clinical benefit
Giving intravenous beta blockers before performing a coronary angioplasty in patients who had experienced the deadliest form of heart attack -- ST-segment elevation myocardial infarction (STEMI) -- was safe but did not reduce heart attack severity or improve blood flow from the heart's main pumping chamber, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

Life-threatening bowel ischemia can often be treated by balloon angioplasty
Acute mesenteric ischemia (AMI) can be successfully treated with endovascular therapy such as balloon angioplasty, according to research from the University of Eastern Finland.

Radial access used less than femoral approach for emergency angioplasty
Although using the radial artery as the access point for angioplasty has been linked to reduced bleeding compared to use of the femoral artery, only a small number of high-risk heart attack patients who undergo rescue angioplasty -- emergency procedures following failed therapy with clot-busting drugs -- are treated by radial access, according to a study published today in the Journal of the American College of Cardiology: Cardiovascular Interventions.

Use of rarely appropriate angioplasty procedures declined sharply
The number of angioplasty procedures classified as rarely appropriate declined sharply between 2010 and 2014, as did the number of those performed on patients with non-acute conditions, according to a study published today in the Journal of the American Medical Association and simultaneously presented at a meeting of the American Heart Association in Orlando.

Read More: Angioplasty News and Angioplasty Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to